2nd Updates on Advanced Breast Cancer: Local Management and Other New Perspectives is organized by The University of Texas MD Anderson Cancer Center and will be held from Feb 28 - 29, 2020 at The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
This conference is targeted for Medical Oncologists, Radiation Oncologists and Surgical Oncologists.
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 12.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Certificates and Attendance Verification Certificates:
Certificates awarding AMA PRA Category 1 CreditTM or certificates documenting attendance will be emailed when an individual completes the online CME Verification process.
Upon request, a record of attendance (certificate) will be provided via email to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
The University of Texas MD Anderson Cancer Center is an approved provider with commendation of continuing nursing education by the Texas Nurses Association- Approver, and accredited approver with distinction, by the American Nurses Credentialing Center’s Commission on Accreditation.
Nurses will be awarded CNE contact hours when requirements for successful completion are met. Nurses must arrive and sign-in no later than 15 minutes after the first session begins and full participation must occur. Nurses must complete an online evaluation that will only be open for 7 consecutive days at the close of the educational activity. A "Certificate of Successful Completion" will be electronically emailed to the address provided.
The goal is for physicians to develop the tools to diagnose, identify therapeutic approaches specifically for treatment of breast cancer, enhance approaches to assist in detecting the disease, evaluate the effectiveness of treatment for advanced breast cancer patients, and appropriately refer patients to clinical trials if needed after the understanding of available therapy.
After attending the conference, participants should be able to:
• Conduct a timely recognition and diagnosis of inflammatory and triple-negative breast cancer, and provide appropriate delivery of therapy that involves multidisciplinary care (Knowledge, Competence, Performance, Patient Outcomes);
• Apply the updated management of locally advanced, recurrent breast cancer (Knowledge, Competence, Performance);
• Apply the updated knowledge on new biological findings/genomic information into clinical translation (Knowledge, Competence, Performance, and Patient Outcomes).
• Case Studies
• Audience Response System
• Interactive Groups/Breakouts
• Internet Live Course
|Contact No. :||713-792-2223
|Registration Type||Last Date||Price|
|Physicians (MDs/PhDs) - Non-HAL/TMC Members - Early Fee||06 Feb,2020||USD 50.00|
|Physicians (MDs/PhDs) - HAL/TMC Members - Early Fee||06 Feb,2020||USD 0.00|
|Healthcare Professionals (RNs/PAs/Trainees) - Early Fee||06 Feb,2020||USD 30.00|
|Patients, Caregivers, Advocates and Volunteers - Early Fee||06 Feb,2020||USD 0.00|
The University of Texas MD Anderson Cancer Center
Duncan Building (CPB), Floor 8, Rooms 1-8, 1155 Pressler Street
Houston, Texas, United States of America
Houston Marriott Medical Center/Museum District,
6580 Fannin St,
Houston, Texas, United States of America 77030,